What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression? Evidence From Selective Neurotransmitter Depletion Studies.

Trial Profile

What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression? Evidence From Selective Neurotransmitter Depletion Studies.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 05 Aug 2014

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Bipolar disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jul 2014 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 10 Apr 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 19 Sep 2011 Planned End Date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top